Nasdaq - Delayed Quote USD

Vanguard Growth & Income Inv (VQNPX)

63.53
+0.17
+(0.27%)
As of 8:09:31 AM EDT. Market Open.

Fund Summary

The fund invests at least 65% (and typically more than 90%) of its assets in stocks that are included in the index. Most of the stocks held by the fund provide dividend income as well as the potential for capital appreciation. The advisors use quantitative approaches to select a broadly diversified group of stocks that, as a whole, have investment characteristics similar to those of the S&P 500 Index, but are expected to provide a higher total return than that of the index.

Vanguard Growth & Income Inv

MALVERN PA 19355-19482
100 VANGUARD BLVD, P.O. BOX 2600
6106691000

Fund Overview

Category Large Blend
Fund Family Vanguard
Net Assets 14.71B
YTD Return -5.12%
Yield 0.91%
Morningstar Rating
Inception Date May 14, 2001

Fund Operations

Last Dividend 0.60
Last Cap Gain 38.00
Holdings Turnover 84.00%
Average for Category --

Fees & Expenses

Expense VQNPX Category Average
Annual Report Expense Ratio (net) 0.36% 0.78%
Prospectus Net Expense Ratio 0.36% --
Prospectus Gross Expense Ratio 0.36% --
Max 12b1 Fee -- --
Max Front End Sales Load -- --
Max Deferred Sales Load -- --
3 Yr Expense Projection 0 --
5 Yr Expense Projection 0 --
10 Yr Expense Projection 0 --

Management Information

Hal W. Reynolds, Lead Manager since September 30, 2011
Hal Reynolds is the Chief Investment Officer of LACM Global. As Chief Investment Officer and Chairman of Los Angeles Capital’s Investment Committee, Mr. Reynolds oversees the firm’s investment process. Since co-founding Los Angeles Capital in 2002, Mr. Reynolds has worked closely with the Research team to develop Investor Preference Theory®, the Dynamic Alpha Stock Selection Model®, and the Forward Attribution® process for developing forwarding looking expected factor returns. Working with the Research Directors, he develops the firm’s research goals and provides guidance on key projects to enhance the stock selection, portfolio construction, and trading processes. As a member of the Portfolio Review Committee, he works with senior members of the portfolio management team to establish key portfolio parameters for portfolio construction and rebalancing and developing procedures for monitoring and controlling portfolio risk. Prior to Los Angeles Capital, Mr. Reynolds was a managing director and principal at Wilshire Associates. Mr. Reynolds joined the consulting division of Wilshire Associates in 1989 where he served as a senior consultant to large ERISA plans. He also designed Wilshire Compass, Wilshire’s asset allocation and manager optimization technology for plan sponsors. In 1996, Mr. Reynolds began consulting for Wilshire Asset Management where he helped develop the Dynamic Alpha Model, which developed into Los Angeles Capital’s Dynamic Alpha Stock Selection Model®, and other quantitative long/short applications for Wilshire Asset Management. In 1998, he joined Wilshire Asset Management as Chief Investment Officer. Prior to joining Wilshire, Mr. Reynolds was a vice president at Mellon Bank where he was responsible for the design and management of Mellon’s portfolio analysis product for plan sponsors.

Morningstar Style Box

Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund. Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund.

Morningstar Category

While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk, and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. When necessary, we may change a category assignment based on recent changes to the portfolio.

Related Tickers

FKRCX Franklin Gold and Precious Metals A
25.63
+2.19%
 
FRGOX Franklin Gold and Precious Metals C
22.04
+2.18%
 
FGADX Franklin Gold and Precious Metals Adv
28.16
+2.18%
 
FGPMX Franklin Gold and Precious Metals R6
28.63
+2.18%
 
INIIX VanEck International Investors Gold I
20.94
+2.05%
 
INIYX VanEck International Investors Gold Y
15.32
+2.00%
 
FEGIX First Eagle Gold I
35.45
+1.72%
 
FEURX First Eagle Gold R6
35.56
+1.72%
 
USERX U.S. Global Investors Gold & Precious Metals Fund
15.88
+1.60%
 
FPHAX Fidelity Select Pharmaceuticals Port
23.67
+1.54%
 
AIVGX American Funds International Vntg F-3
19.06
+1.38%
 
FSHCX Fidelity Select Health Care Svcs Port
102.66
+1.38%
 
FNORX Fidelity Nordic
66.52
+1.37%
 
BIPSX ProFunds Biotechnology UltraSector Fund
19.11
+1.33%
 
BIPIX ProFunds Biotechnology UltraSector Fund
36.74
+1.32%
 
FIJYX Fidelity Advisor Biotechnology Z
27.61
+1.28%
 
APHIX Artisan International Fund
32.71
+1.18%
 
APDIX Artisan International Fund
32.34
+1.16%
 
ARTIX Artisan International Investor
32.51
+1.15%
 
BISAX Brandes International Small Cap Equity Fund
22.86
+1.11%
 
BISMX Brandes International Small Cap Equity Fund
23.03
+1.10%
 
BISRX Brandes International Small Cap Equity Fund
23.20
+1.09%
 
CPAEX Counterpoint Tactical Equity A
22.52
+1.08%
 
GIEYX GuideStone Funds International Eq Instl
15.98
+1.08%
 
BINCX Brandes International Small Cap Equity Fund
21.82
+1.07%
 
CPCEX Counterpoint Tactical Equity C
21.00
+1.06%
 
CPIEX Counterpoint Tactical Equity I
23.03
+1.05%
 
CIVVX Causeway International Value Inv
21.39
+1.04%
 
CIVIX Causeway International Value Instl
21.59
+1.03%
 
GIEZX GuideStone Funds International Eq Inv
15.93
+1.01%
 
FGRSX Federated Hermes Intl Leaders R6
41.88
+1.01%
 
FGFAX Federated Hermes International Leaders A
41.89
+1.01%
 
FGFLX Federated Hermes Intl Leaders IS
41.94
+1.01%
 
AIONX AQR International Momentum Style N
17.08
+1.01%
 
FSPHX Fidelity Select Health Care
25.19
+1.00%
 
PJHRX PGIM Jennison Health Sciences R
28.80
+0.98%
 
PHLQX PGIM Jennison Health Sciences R6
40.53
+0.97%
 
QIORX AQR International Momentum Style R6
16.66
+0.97%
 
PHLAX PGIM Jennison Health Sciences A
31.27
+0.97%
 
AIMOX AQR International Momentum Style I
16.72
+0.97%
 
PHSZX PGIM Jennison Health Sciences Z
40.11
+0.96%
 
MGLBX Marsico Global
28.63
+0.95%
 
JFNAX Janus Henderson Global Life Sciences Fund
63.11
+0.94%
 
JAGLX Janus Henderson Global Life Sciences T
64.30
+0.94%
 
HAORX Harbor International Core Retirement
15.02
+0.94%
 
NOINX Northern International Equity Index
16.10
+0.94%
 
FIDZX Fidelity Advisor Intl Cap App Z
36.53
+0.94%
 
JFNSX Janus Henderson Global Life Sciences Fund
61.32
+0.94%
 
JFNNX Janus Henderson Global Life Sciences Fund Class N Shares
64.61
+0.94%
 
JNGLX Janus Henderson Global Life Sciences D
64.72
+0.94%
 
JFNIX Janus Henderson Global Life Sciences Fund
64.85
+0.93%
 
FIVFX Fidelity International Capital Apprec
31.44
+0.93%
 
JFNCX Janus Henderson Global Life Sciences Fund
54.26
+0.93%
 
FIATX Fidelity Advisor Intl Cap App M
32.67
+0.93%
 
FCPAX Fidelity Advisor Intl Capl App A
33.78
+0.93%
 
FAERX Fidelity Advisor Overseas M
37.37
+0.92%
 
FOSKX Fidelity Overseas K
72.62
+0.92%
 
FCPCX Fidelity Advisor Intl Cap App C
28.61
+0.92%
 
FAOSX Fidelity Advisor Overseas Z
37.46
+0.92%
 
FAOAX Fidelity Advisor Overseas A
36.39
+0.92%
 
FCPIX Fidelity Advisor Intl Cap App I
36.42
+0.91%
 
FAOIX Fidelity Advisor Overseas I
37.53
+0.91%
 
FOSFX Fidelity Overseas
73.03
+0.91%
 
MIOFX Marsico International Opportunities
27.73
+0.91%
 
MRFOX Marshfield Concentrated Opportunity
33.75
+0.90%
 
PIEQX T. Rowe Price International Eq Index
18.26
+0.88%
 
FSPSX Fidelity International Index
55.39
+0.87%
 
SAHMX SA International Value
15.02
+0.87%
 
COBYX The Cook & Bynum
17.34
+0.87%
 
FZABX Fidelity Advisor Diversified Intl Z
29.00
+0.87%
 
PRHSX T. Rowe Price Health Sciences
75.44
+0.87%
 
CVISX Causeway International Small Cap Inv
15.11
+0.87%
 
CIISX Causeway International Small Cap Instl
15.13
+0.87%
 
THISX T. Rowe Price Health Sciences I
75.66
+0.87%
 
CIOVX Causeway International Opps Inv
17.60
+0.86%
 
GMCFX GMO International Equity Fund
29.41
+0.86%
 
GMOIX GMO International Equity Fund
29.45
+0.86%
 
CIOIX Causeway International Opps Inst
17.76
+0.85%
 
FSDAX Fidelity Select Defense & Aerospace
21.56
+0.84%
 
RRIGX T. Rowe Price International Value Eq R
20.41
+0.84%
 
TROZX T. Rowe Price International Value Eq Z
20.44
+0.84%
 
GDLFX Gotham Defensive Long 500 Institutional
19.26
+0.84%
 
QICLX AQR International Multi-Style I
15.66
+0.84%
 
TRIGX T. Rowe Price International Value Eq
20.55
+0.83%
 
PAIGX T. Rowe Price International Value Eq Adv
20.83
+0.82%
 
EIISX Parametric International Equity I
16.07
+0.82%
 
TEQAX Touchstone Non-US Equity A
28.58
+0.81%
 
UIIFX Victory International Fund
29.84
+0.81%
 
NAIGX Nuveen International Value A
32.35
+0.81%
 
CSXAX Calvert US Large Cap Core Rspnb Idx A
49.79
+0.81%
 
USIFX Victory International Fund
29.96
+0.81%
 
CISIX Calvert US Large Cap Core Rspnb Idx I
51.25
+0.81%
 
TIQIX Touchstone Non-US Equity Y
30.01
+0.81%
 
BHSRX BlackRock Health Sciences Opportunities Portfolio
58.78
+0.81%
 
TROCX Touchstone Non-US Equity I
30.04
+0.81%
 
SHISX BlackRock Health Sciences Opps Svc
61.39
+0.80%
 
TEQCX Touchstone Non-US Equity C
28.96
+0.80%
 
URITX Victory International Fund
30.32
+0.80%
 
SHSSX BlackRock Health Sciences Opps Instl
65.80
+0.80%
 
SHSKX BlackRock Health Sciences Opps K
65.94
+0.79%